162 related articles for article (PubMed ID: 22538188)
1. Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.
Nagaishi M; Kim YH; Mittelbronn M; Giangaspero F; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Legras-Lachuer C; Lachuer J; Ohgaki H
Am J Pathol; 2012 May; 180(5):1816-23. PubMed ID: 22538188
[TBL] [Abstract][Full Text] [Related]
2. Genetic profile of gliosarcomas.
Reis RM; Könü-Lebleblicioglu D; Lopes JM; Kleihues P; Ohgaki H
Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma.
Nagaishi M; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Giangaspero F; Ohgaki H
Brain Pathol; 2012 Sep; 22(5):670-6. PubMed ID: 22288519
[TBL] [Abstract][Full Text] [Related]
4. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.
Boerman RH; Anderl K; Herath J; Borell T; Johnson N; Schaeffer-Klein J; Kirchhof A; Raap AK; Scheithauer BW; Jenkins RB
J Neuropathol Exp Neurol; 1996 Sep; 55(9):973-81. PubMed ID: 8800093
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
6. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
[TBL] [Abstract][Full Text] [Related]
7. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
[TBL] [Abstract][Full Text] [Related]
8. Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
Dardis C; Donner D; Sanai N; Xiu J; Mittal S; Michelhaugh SK; Pandey M; Kesari S; Heimberger AB; Gatalica Z; Korn MW; Sumrall AL; Phuphanich S
BMC Neurol; 2021 Jun; 21(1):231. PubMed ID: 34162346
[TBL] [Abstract][Full Text] [Related]
9. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Rodriguez FJ; Scheithauer BW; Giannini C; Bryant SC; Jenkins RB
Cancer; 2008 Nov; 113(10):2779-89. PubMed ID: 18816605
[TBL] [Abstract][Full Text] [Related]
10. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
[TBL] [Abstract][Full Text] [Related]
11. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
[TBL] [Abstract][Full Text] [Related]
13. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature.
Ozolek JA; Finkelstein SD; Couce ME
Mod Pathol; 2004 Jun; 17(6):739-45. PubMed ID: 15148503
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia.
Dahlback HS; Gorunova L; Micci F; Scheie D; Brandal P; Meling TR; Heim S
Cytogenet Genome Res; 2011; 134(2):88-95. PubMed ID: 21555877
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcoma with ependymal and PNET-like differentiation.
Shintaku M; Yoneda H; Hirato J; Nagaishi M; Okabe H
Clin Neuropathol; 2013; 32(6):508-14. PubMed ID: 23863343
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma with chondroid and osseous differentiation.
Schittenhelm J; Erdmann T; Maennlin S; Will BE; Beschorner R; Bornemann A; Meyermann R; Mittelbronn M
Neuropathology; 2007 Feb; 27(1):90-4. PubMed ID: 17319288
[TBL] [Abstract][Full Text] [Related]
17. Spindle-cell glioblastoma or gliosarcoma?
Jones H; Steart PV; Weller RO
Neuropathol Appl Neurobiol; 1991 Jun; 17(3):177-87. PubMed ID: 1653908
[TBL] [Abstract][Full Text] [Related]
18. Gliosarcomas arising from the pineal gland region: uncommon localization and rare tumors.
Sugita Y; Terasaki M; Tanigawa K; Ohshima K; Morioka M; Higaki K; Nakagawa S; Shimokawa S; Nakashima S
Neuropathology; 2016 Feb; 36(1):56-63. PubMed ID: 26183264
[TBL] [Abstract][Full Text] [Related]
19. Sarcoma arising as a distinct nodule within glioblastoma: a morphological and molecular perspective on gliosarcoma.
Jimenez C; Powers M; Parsa AT; Glastonbury C; Hagenkord JM; Tihan T
J Neurooncol; 2011 Nov; 105(2):317-23. PubMed ID: 21533839
[TBL] [Abstract][Full Text] [Related]
20. Gliosarcoma: report of four cases with immunohistochemical findings.
Machuca TN; Prevedello DM; Pope LZ; Haratz SS; Araújo JC; Torres LF
Arq Neuropsiquiatr; 2004 Sep; 62(3A):608-12. PubMed ID: 15334217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
